Search filters

List of works by Arnt V Kristen

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging

scientific article published on 29 August 2019

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization

scientific article published on 29 August 2019

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging

scientific article published on 01 December 2019

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization

scientific article published on 29 August 2019

Anterior Aortic Plane Systolic Excursion: A Novel Indicator of Transplant-Free Survival in Systemic Light-Chain Amyloidosis.

scientific article

Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay

scientific article published on 25 June 2010

Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO Study

scientific article published on 01 May 2019

Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis

scientific article published on 01 January 2019

Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosis

scientific article published in August 2014

Green tea halts progression of cardiac transthyretin amyloidosis: an observational report

scientific article

High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study

scientific article published in December 2004

Indications for high-dose chemotherapy with autologous stem cell support in patients with systemic amyloid light chain amyloidosis

scientific article

Indications for liver transplantation in patients with amyloidosis: a single-center experience with 11 cases

scientific article published in September 2005

Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up.

scientific article published on 18 May 2017

Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers

scientific article published on 8 August 2012

Myocardial contraction fraction derived from cardiovascular magnetic resonance cine images-reference values and performance in patients with heart failure and left ventricular hypertrophy

scientific article published on 01 December 2017

Non-invasive predictors of survival in cardiac amyloidosis

scientific article published on 09 March 2007

Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis

scientific article published on 9 July 2014

Peak V'O2 is an independent predictor of survival in patients with cardiac amyloidosis

scientific article published on 07 September 2018

Predictors of survival stratification in patients with wild-type cardiac amyloidosis.

scientific article

Prognostic significance of semiautomatic quantification of left ventricular long axis shortening in systemic light-chain amyloidosis.

scientific article published on 10 December 2014

Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death.

scientific article published on 9 October 2007

Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis

scientific article published on 04 March 2020

Rapid progression of left ventricular wall thickness predicts mortality in cardiac light-chain amyloidosis

scientific article published on 26 November 2007

Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience

scientific article published on 07 December 2020

Respiratory muscle weakness and inefficient ventilation in heart failure due to light-chain amyloidosis

Risk stratification in cardiac amyloidosis: novel approaches

scientific article

Skeletal scintigraphy indicates disease severity of cardiac involvement in patients with senile systemic amyloidosis

scientific article published on 20 July 2011

Staged heart transplantation and chemotherapy as a treatment option in patients with severe cardiac light-chain amyloidosis

scientific article published on 01 October 2009

Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement

scientific article published on 07 April 2010

Paulina is supported by:

About Paulina

Help